Genetic test identifies “high risk” lymphatic cancer patients

Patients with mantle cell lymphoma are more likely to relapse if they carry mutations in the cancer gene, TP53. The results could help provide more targeted treatments for this “high risk” group.

Latest news

Syndicate content

Jobs

Follow ScienceNordic on: